Product Details

Vermag-S is a sterile injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Magnesium Sulphate at 1g per 10ml for intravenous use in the correction of magnesium deficiency and related conditions. As a result, it offers a reliable electrolyte replacement and anticonvulsant option for critical care and obstetric settings.

The injection contains:

• Magnesium Sulphate BP (as Magnesium Sulphate Heptahydrate, 1g per 10ml) – An essential electrolyte that acts as a physiological calcium antagonist at the neuromuscular junction and central nervous system. Consequently, it stabilizes cardiac and neuromuscular excitability, supports normal cellular function, and reduces seizure threshold-related activity.

Physicians use Vermag-S for the correction of hypomagnesaemia and as part of the management of eclampsia and severe pre-eclampsia, where magnesium plays a key anticonvulsant role. In addition, it supports the treatment of certain cardiac arrhythmias, such as torsades de pointes, where rapid magnesium correction is essential. Because of this profile, Vermag-S suits obstetric units, ICUs, and emergency departments where prompt electrolyte and neuromuscular stabilization is required.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the single-dose vial format minimizes contamination risk
• Furthermore, each vial delivers precise, validated dosage accuracy at 1g/10ml
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected vial packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, obstetric units, and ICUs